Conference Coverage
Conference Coverage
Atorvastatin cut anthracycline cardiac dysfunction in lymphoma
Conference Coverage
Prostate cancer subgroup may benefit from intensified therapy
A new trial explored whether for patients with prostate cancer who have unfavorable features and a detectable PSA following a radical...
Conference Coverage
Talazoparib add-on improves outcomes in metastatic prostate cancer
As determined on the basis of imaging, PFS was 37% better for talazoparib plus enzalutamide than for enzalutamide monotherapy.
Conference Coverage
Adjuvant nivolumab as standard of care in resected bladder cancer
Compared with placebo, nivolumab improves disease-free survival, nonurothelial tract recurrence-free survival, and distant metastasis-free...
Conference Coverage
CML: Preventing chemo-induced vascular toxicity
Cardiologists advise on how to ward off side effects linked to 2 TKI treatments for chronic myeloid leukemia.
Latest News
Expert discusses pros, cons of molecular tests for melanoma
Next generation sequencing allows for the generation of millions of sequencing reads that are aligned to a standard human genome, and likely...
Conference Coverage
Rucaparib benefit in BRCA+ prostate cancer confirmed
New study finding provides evidence of clinical benefit for an indication for rucaparib that was granted an accelerated approval in May 2020.
Latest News
How prevalent is pediatric melanoma?
As in adults, the stage correlates strongly with survival, and distant metastases carry a poor prognosis.
Latest News
Optimal management of dysplastic nevi continues to evolve
“Misdiagnosis is more common for melanomas that have been assessed with punch and shave biopsies than with an excisional biopsy,” Dr. Benjamin...
Latest News
More than 97K new cutaneous melanoma diagnoses expected in 2023
More than 1.3 million people in the United States live with cutaneous melanoma, and the overall 5-year survival is 93.7%.
Latest News
Dermoscopy, other modalities for improving melanoma diagnoses reviewed
The learning curve for dermoscopy is steep, he added, and whether the technique should be considered a first-line tool or as a supplement to other...